Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension레닌-안지오텐신계 억제제는 고혈압 환자의 임상 결과를 개선합니다.Letter Published on 2020-03-312022-09-06 Journal: Emerging Microbes & Infections [Category] Communicable Disease, COVID-19, MERS, SARS, [키워드] ACEi ACEIs addition angiotensin Angiotensin II angiotensin II type 1 receptor blockers angiotensin II type1 receptor blockers angiotensin-converting enzyme inhibitor angiotensin-converting enzyme inhibitors antihypertensive drugs ARB ARBs benefit blocker CD3 CD8 T cell Clinical outcome clinical outcomes contribute Coronavirus infection coronavirus infection disease COVID-19 COVID-19 patient COVID-19 patients dysfunction enrolled evaluate the effect Evidence hypertension IL-6 IMPROVE inhibitor Patient patients Peripheral blood RAS RAS inhibitors receiving receptor Receptor Blockers Renin renin-angiotensin system severe disease Support T cell therapy Viral Viral load [DOI] 10.1080/22221751.2020.1746200 PMC 바로가기 [Article Type] Letter
Arterial hypertension and COVID-19 infections: A brief commentaryArticle Published on 2020-01-012023-07-14 Journal: Vnitr̆ní lékar̆ství [Category] SARS, [키워드] antihypertensive drugs COVID-19 hypertension